Plantable Health Inc.

Recent News

  • Plantable Health Provides a Solution for Healthcare Plans Seeking Savings in Chronic Conditions with the RebootRX

    New York, New York--(Newsfile Corp. - September 29, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company") announced its plans to expand the Company's reach into the self-funded marketplace with the launch of the RebootRx. Proven on the individual level, Plantable's RebootRx product will offer self-funded employers a value-based solution to reverse chronic disease with high levels of adherence and engagement, leading to better outcomes both for the individual's health and for the employer's bottom line....

    2022-09-29 7:00 PM EDT
  • Plantable Health Inc. Reports Second Quarter Financial Results

    New York, New York--(Newsfile Corp. - August 9, 2022) - Plantable Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company"), a clinically supported dietary intervention program to reverse and prevent chronic disease, today reported the Company's financial results for the second quarter ended June 30, 2022."When we founded Plantable, the concept of having a turnkey solution that reversed diet-related chronic disease, paid for by the insurer, was novel. We were very early," said Nadja Pinnavaia Ph.D., CEO of Plantable....

    2022-08-09 7:00 AM EDT
  • Plantable Health's Randomized Control Trial Opens Enrollment for Prostate Cancer Patients

    New York, New York--(Newsfile Corp. - July 19, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company") today announces that its Prostate Cancer Trial at Weill Cornell Medicine, NewYork-Presbyterian and at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center ("John Hopkins") has commenced enrollment. This multi-center randomized control trial led by David M. Nanus, MD., a medical oncologist and clinical investigator at Weill Cornell Medicine, NewYork-Presbyterian and John Hopkins, studies Plantable as a dietary intervention to control...

    2022-07-19 8:45 AM EDT
  • Plantable Health Welcomes James (Jim) Wachtel as Chief Growth Officer

    New York, New York--(Newsfile Corp. - June 2, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company") today announces it has finalized its senior management team with the hiring of James (Jim) Wachtel as Chief Growth Officer (CGO) effective June 2, 2022. Jim will lead all new business growth, adding to the Company's aggressive growth strategy, with a primary responsibility of driving Plantable's institutional partnership growth across self-funded employers, health plans, hospital systems, and other relevant...

    2022-06-02 8:45 AM EDT
  • Plantable Health Inc. Announces March 2022 First Quarter Financial Results

    New York, New York--(Newsfile Corp. - May 13, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company"), a clinically supported dietary intervention program to reverse and prevent chronic disease, today announced the financial results for the three months ended March 31, 2022.The quarter end consolidated interim financial statements were prepared in accordance with the International Accounting Standards ("IAS") 34, Interim Financial Reporting, under International Financial Reporting Standards ("IFRS"). All amounts herein are expressed in United...

    2022-05-13 8:45 AM EDT
  • Plantable Health Completes Upgrade of U.S. Listing on the OTCQB Market and Announces Quarterly Earnings Call

    New York, New York--(Newsfile Corp. - May 10, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company") announces that its common shares have been successfully upgraded to trade on the OTCQB® Venture Market (the "OTCQB") under the symbol "PLBLF" and now are eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the United States; effective at the open of trading on May 9, 2022. The Company's common shares are now cross-listed and...

    2022-05-10 7:00 PM EDT
  • Plantable Health Announces Partnership with Leading Sustainable Packaging Supplier, Grounded

    New York, New York--(Newsfile Corp. - April 22, 2022) - Plantable® Health Inc. (NEO: PLBL) ("Plantable" or the "Company") today announces it has selected Grounded Packaging ("Grounded") as its new packaging supplier, providing carbon negative, recyclable packaging materials made from plant-based bioplastics.Grounded's Sugarflex™ materials made from sustainable sugarcane will help Plantable achieve a carbon negative footprint for its new packaging. With the move to Grounded's Biovac™ bags, Plantable projects to replace over 2,114 kgs of virgin fossil fuel and with...

    2022-04-22 8:45 AM EDT
  • Plantable Health Provides Corporate Update

    New York, New York--(Newsfile Corp. - April 19, 2022) - Plantable® Health Inc. (NEO: PLBL) ("Plantable" or the "Company") today announces the following corporate update to share the status of the Company and its various initiatives planned for the remainder of 2022.CEO Dr. Nadja Pinnavaia stated: "We have made progress since going public at the start of this year. We have been proactive and strategic in optimizing new marketing initiatives to increase exposure, from which we have already seen improved...

    2022-04-19 8:45 AM EDT